AIDS (London, England) - JoVE Visualize

Showing results (671-680 of 10,440) with videos related to

Pageof 1,044

Sort By:

AIDS (London, England)|November 5, 1999

Changes in HIV-related risk behaviors following drug abuse treatmentW J Woods, J R Guydish, J L Sorensen, et al.

AIDS (London, England)|April 15, 1999

Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavirP Tebas, A K Patick, E M Kane, et al.

AIDS (London, England)|April 15, 1999

Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.

AIDS (London, England)|April 15, 1999

Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patientsJ E Gallant, R E Chaisson, J C Keruly, et al.

AIDS (London, England)|April 15, 1999

Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapyM D Van Loan, A Strawford, M Jacob, et al.

AIDS (London, England)|April 15, 1999

Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choiceA E Ades, R Gupta, D M Gibb, et al.

AIDS (London, England)|April 10, 1999

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)P Musoke, L A Guay, D Bagenda, et al.

AIDS (London, England)|April 15, 1999

Stable antenatal HIV-1 seroprevalence with high population mobility and marked seroprevalence variation among sentinel sites within Nairobi, KenyaD J Jackson, E N Ngugi, F A Plummer, et al.

AIDS (London, England)|April 20, 1999

Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, D R Harris, K Rich, et al.

AIDS (London, England)|April 20, 1999

Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patientsC Tascini, A Vecchiarelli, R Preziosi, et al.

Pageof 1,044

Showing results (671-680 of 10,440) with videos related to

Sort By:

Pageof 1,044

AIDS (London, England)|November 5, 1999

Changes in HIV-related risk behaviors following drug abuse treatmentW J Woods, J R Guydish, J L Sorensen, et al.

AIDS (London, England)|April 15, 1999

Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavirP Tebas, A K Patick, E M Kane, et al.

AIDS (London, England)|April 15, 1999

Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.

AIDS (London, England)|April 15, 1999

Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patientsJ E Gallant, R E Chaisson, J C Keruly, et al.

AIDS (London, England)|April 15, 1999

Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapyM D Van Loan, A Strawford, M Jacob, et al.

AIDS (London, England)|April 15, 1999

Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choiceA E Ades, R Gupta, D M Gibb, et al.

AIDS (London, England)|April 10, 1999

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)P Musoke, L A Guay, D Bagenda, et al.

AIDS (London, England)|April 15, 1999

Stable antenatal HIV-1 seroprevalence with high population mobility and marked seroprevalence variation among sentinel sites within Nairobi, KenyaD J Jackson, E N Ngugi, F A Plummer, et al.

AIDS (London, England)|April 20, 1999

Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, D R Harris, K Rich, et al.

AIDS (London, England)|April 20, 1999

Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patientsC Tascini, A Vecchiarelli, R Preziosi, et al.

Pageof 1,044